Sign Out
Cave during use in patients with bronchial asthma and in patients with anamnestic ulcers.
The use of acetylcysteine, especially in early treatment can lead to liquefaction and thus to an increase in volume of bronchial secretions. If the patient is unable to expectorate (sufficiently expectorate), appropriate measures (such as drainage and aspiration) should be performed.
The occurrence of severe skin reactions such as Stevens-Johnson syndrome and Lyell's syndrome has very rarely been reported in temporal connection with use of acetylcysteine. If cutaneous and mucosal changes newly occur, medical advice should be sought without delay and use of acetylcysteine be terminated.
Effects on ability to drive and use machines: None known.
Continue with Google